MATN3 and cancer: Based on TCGA and GTEx databases, our work found that MATN3 was significantly up-regulated in 15 cancer types, and MATN3 expression was relatively high in a variety of cancer types in relatively high T stage, relatively high N stage, relatively high M stage, and higher histologic grading.